Abstract: A ceramic electronic component includes a body including a dielectric layer and an internal electrode; and an external electrode disposed on the body and connected to the internal electrode. The dielectric layer includes a plurality of grains and grain boundaries disposed between adjacent grains. The grain boundary includes a secondary phase including Sn, a rare-earth element, and a first subcomponent. The rare-earth element includes at least one of Y, Dy, Ho, Er, Gd, Ce, Nd, Sm, Tb, Tm, La, Gd and Yb. The first subcomponent includes at least one of Si, Mg, and Al.

Abstract: An image processing device including: a decision pixel manager for setting a decision area for a defect candidate pixel, and determining a first decision pixel and a second decision pixel, based on first phase information of pixels included in the decision area with respect to a first modulation frequency of a sensing light source among the pixels; a target pixel determiner for calculating a phase difference between the first decision pixel and the second decision pixel, based on second phase information of the pixels with respect to a second modulation frequency of the sensing light source, and determining the defect candidate pixel as a target pixel, corresponding to that the phase difference exceeds a predetermined reference value; and a phase corrector for changing a phase of the target pixel, based on the phase difference.

Abstract: Proposed is a method of manufacturing a carbon precursor fiber for a gas diffusion layer having excellent tensile properties (e.g., strength and modulus) by controlling the cross-sectional shape of carbon fiber. The method includes preparing a polyacrylonitrile-based copolymer, preparing spinning products by spinning a spinning solution containing the polyacrylonitrile-based copolymer in a coagulation bath, and obtaining a carbon precursor fiber by drawing the spinning products through heat treatment. The coagulation bath includes an amount of about 60% to 90% by volume of methanol and an amount of about 10% to 40% by volume of dimethylformamide based on the total volume of the coagulation bath.

Abstract: The present invention relates to a perovskite metal oxide catalyst substituted with metal ions for reducing carbon deposition, a method for producing the same, and a process for performing a methane reforming reaction using this catalyst. According to the present invention, a novel type of catalyst is produced in which Ni, iron or cobalt in ionic form is substituted at a portion of the Ti site (B-site) of SrTiO3, MgTiO3, CaTiO3 or BaTiO3, which is a multicomponent metal oxide having a perovskite (ABO3) structure. Then, various methane reforming reactions (e.g., steam-methane reforming (SMR), dry reforming of methane (DRM), catalytic partial oxidation of methane (CPOM), etc.) may be efficiently and economically performed using this catalyst. The nickel-substituted perovskite metal oxide catalyst according to the present invention has a structure in which Ni2+, Co2+, Fe2+, Co3+ or Fe3+ is substituted in the perovskite lattice structure.

Abstract: An embodiment vehicle door opening/closing system includes an inner panel defining a door open portion of a vehicle, the inner panel including an installation groove having a protruding or recessed shape, a driving device disposed in the installation groove of the inner panel, and a link mechanism installed on a chassis through a rotating shaft, a first end of the link mechanism being connected to the driving device such that power is transferred thereto, and a second end of the link mechanism being connected to a door such that, during driving of the driving device, the link mechanism rotates with reference to the rotating shaft to open/close the door.

Abstract: The present disclosure is a pharmaceutical composition for the prevention or treatment of sepsis containing a thiamine derivative or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical composition of the present disclosure can be used for the prevention, alleviation, or treatment of sepsis by containing fursultiamine or allithiamine to inhibit the expressions of CD40, CD86, and TNF?.

Abstract: The present invention relates to a pharmaceutical composition for preventing, treating, or ameliorating graft versus host disease (GVHD), comprising thiamine derivatives, in which the active ingredient of the pharmaceutical composition is fursultiamine, which can alleviate weight loss found in patients with GVHD, reduce the infiltration of liver and colon inflammatory cells, and effectively inhibit the production of allogeneic CD4+ IFN?+ T cells, and thus can be effectively used for the prevention, treatment, or amelioration of GVHD.

Abstract: A visible light-reactive photocatalyst includes: a metal-organic framework (MOF) including pores; and an active material doped on the surface of the metal-organic framework, wherein the active material includes molybdenum disulfide (MoS2) or titanium oxide (TiO2).

Abstract: A system which provides disaster notification contents includes: a DNC collecting module configured to communicate with a disaster notification contents (DNC) sending agency server and collect various DNCs; a DNC sending determination module configured to read the DNC collected by the DNC collecting module, check a DNC-related area, compare the DNC-related area with a preset user disaster interest area, and determine users whose disaster interest area matches the DNC-related area as DNC sending target users among the pre-stored users based on the result of comparison; and a DNC sending processing module configured to communicate with the DNC sending determination module, read the DNC sending target users list determined as DNC sending target users, and send the DNC collected by the DNC collecting module to the user information device owned by users included in the DNC sending target user list.

Abstract: The present disclosure is a pharmaceutical composition for the prevention or treatment of sepsis containing a thiamine derivative or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical composition of the present disclosure can be used for the prevention, alleviation, or treatment of sepsis by containing fursultiamine or allithiamine to inhibit the expressions of CD40, CD86, and TNF?.

Abstract: The present invention relates to a composition for helping with joint health or preventing, alleviating or treating rheumatoid arthritis and osteoarthritis, which is based on the results of tests conducted using an inflammatory cell model, an osteoarthritis animal model and an acute arthritis animal model.

Abstract: The present invention relates to the composition according to the present invention, which has not only the effect of suppressing inflammation and pain, which are the common symptoms of acute and chronic arthritis, but also the effect of alleviating movement disorders, which are the symptoms of chronic arthritis.